X4 Pharmaceuticals
Barbara Maierhofer is an experienced professional who has worked in various roles in the field of research and lab management. Barbara began their career at Intercell AG, now known as Valneva, before moving on to Arsanis. Currently, Barbara holds the position of Junior Scientist at X4 Pharmaceuticals. Barbara holds an Engineer's degree in Chemistry and Biology from Hochschule Fresenius and a degree in Chemistry from HBLVA Rosensteingasse.
This person is not in any offices
X4 Pharmaceuticals
3 followers
X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and certain cancers. The company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance.